Discover 3,600 paid clinical trials in Glendale, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 3,600
Use of Levocarnitine to Reduce Asparaginase Hepatotoxicity in Patients With Acute Lymphoblastic Leukemia
for
Acute Lymphoblastic Leukemia, Hepatotoxicity
Location: Orange CA
Sponsor: Children's Hospital of Orange County
Sex: All
Age: 5 - 29
Code: NCT05501899
Early Phase 1, Recruiting
Testing the Addition of an Anti-Cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment (Capecitabine) for Metastatic or Unresectable Cancers
for
Metastatic Colorectal Carcinoma,
Location: Orange CA, Irvine CA, Oklahoma City OK, Fairway KS,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT05803382
Phase 1, Recruiting
Safety and Efficacy Study of an Interactive Wound Dressing (KC002) for the Treatment of Diabetic Foot Ulcers
for
Foot Ulcer, Diabetes
Location: Los Angeles CA, Fresno CA, St. George UT,
Sponsor: KeraCure
Sex: All
Age: 18+
Code: NCT00330265
Phase 2, Recruiting
De-escalated Radiation for Human Papillomavirus-Positive Squamous Cell Carcinoma of the Oropharynx
Location: Orange CA, Las Vegas NV, Oklahoma City OK, Omaha NE,
Sponsor: University Medical Center Groningen
Sex: Female
Age: 18+
Code: NCT05076942
Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Randomized, Double-blind, Parallel-group, Two-arm, Multiple Dose, Multicenter, Bioequivalence Study With Clinical Endpoint in the Treatment of Subjects With Chronic Open-angle Glaucoma or Ocular Hypertension in Both Eyes
for
Open-angle Glaucoma, Ocular Hypertension
Location: Newport Beach CA, Bakersfield CA, Houston TX, Morrow GA
Sponsor: Amneal Pharmaceuticals, LLC
Sex: All
Age: 18+
Code: NCT06267274
Phase 1, Recruiting
A Phase 1b Study of Menin Inhibitor SNDX- 5613 in Combination With Daunorubicin and Cytarabine in Newly Diagnosed Patients With Acute Myeloid Leukemia and NPM1 Mutated/FLT3 Wildtype or MLL/KMT2A Rearranged or NUP98 Alterations Disease
for
Acute Myeloid Leukemia,
Location: Orange CA, Salt Lake City UT, Oklahoma City OK,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18 - 70+
Code: NCT05886049
Phase 1, Recruiting
An Optimal Dose Finding Study of N-Acetylcysteine in Patients With Myeloproliferative Neoplasms
Study of ctDNA Guided Change in Tx for Refractory Minimal Residual Disease in Colon Adenocarcinomas
for
Colon Adenocarcinoma, Colorectal Cancer
Location: Orange CA
Sponsor: University of California, Irvine
Sex: All
Age: 18+
Code: NCT04920032
Phase 1, Recruiting
Testing the Addition of an Anti-Cancer Drug, Abemaciclib, to the Usual Chemotherapy Treatment (5-Fluorouracil) for Metastatic, Refractory Colorectal Cancer